Register for Updates

Videos

Join fellow healthcare professionals from across Australia for a peer-to-peer exchange of knowledge and clinical experience with biosimilar medicines. The video talk series, presentations and educational sessions provide insights into a range of areas for biosimilar medicines.

Video Talk Series
A FOCUS ON PEER-TO-PEER DISCUSSION AND EXPERIENCE

Join fellow healthcare professionals from across Australia for a peer-to-peer exchange of knowledge and clinical experience with biosimilar medicines.

Jatinder Harchowal
Chief Pharmacist, Royal Marsden NHS Foundation Trust

Jatinder Harchowal provides an international perspective on the use of biosimilar medicines in the United Kingdom.

Professor Brendan Murphy
Chief Medical Officer, Australian Government

Professor Brendan Murphy is the Chief Medical Officer for the Australian Government and is the principal medical adviser to the Minister and the Department of Health.

Professor Paul Bird
Rheumatologist

Prof Bird has over twenty years' experience in treating rheumatic disease, with particular expertise in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

A/Professor Andrew Östör
Rheumatologist

A/Prof Östör MD, MA, MB BS, FRACP, FRCP, FRCP (Edin), is a Consultant Rheumatologist at Cabrini Medical Centre and Principle Investigator at Emeritus Research, Melbourne.

Professor Jeff Szer
Haematologist

Prof Szer has particular expertise in malignant haematology and haemopoietic stem cell transplantation, which he established as a form of therapy in Victoria in the early 1980s.

Professor John Zalcberg
Oncologist

Prof Zalcberg is Head of the Cancer Research Program in the School of Public Health and Preventive Medicine at Monash University.

Professor Stephen Clarke
Oncologist

Prof Clarke is a medical oncologist, pharmacologist and translational researcher with major clinical and research interests in gastrointestinal and thoracic cancers.

Professor Rodney Sinclair
Dermatologist

Prof Sinclair is Professor of Dermatology at the University of Melbourne and Director of Epworth Dermatology. He is past-president of the Australasian Society for Dermatology Research.

Dr. Lena Thin
Gastroenterologist

Dr Thin is a consultant gastroenterologist at Fiona Stanley Hospital, a position she has held for 8 years. Dr Thin is the lead clinical trials investigator for the IBD unit.

Dr. Simon Ghaly
Gastroenterologist

Dr Ghaly is Head of the Inflammatory Bowel Disease Service and Staff Specialist at St. Vincent’s Hospital, Sydney. He is also a lecturer at the School of Medicine, UNSW Sydney.

David Ford
Pharmacist

Executive Director Pharmacy and Redevelopment, North East Health, and owner and Director, David Ford Healthcare Consulting.

Barry Jenkins
pharmacist

Barry has enjoyed a diverse career beginning in community pharmacy and moving into regional and remote hospital pharmacy in WA and far North QLD.

GBMA Education Grant Activities
Hon Greg Hunt MP, Minister for Health

“Welcome everybody to the Generic and Biosimilar Medicines Association awareness week discussion”

Dr Paul Cornes, UK Oncologist
APP2018: Biosimilar medicines – the case for change

Dr Cornes is an oncologist in Bristol. He is part of the steering group for the European School of Oncology Working Party on the Access to Innovation in Cancer Treatment.

David Ford
Pharmacy Connect 2018: Biologics and biosimilars

David Ford is a proven hospital executive with 30 years of clinical and management experience in hospital administration and department directorship.

A/Professor Michael Ward
APP2019: Biosimilar Update

A/Prof Ward continues to practice as a pharmacist and has research interests broadly related to the factors that influence variability in the safety and efficacy of medicines.

Benefits and cost savings
INTERDISCIPLINARY INSIGHTS

Listen to various experts discuss the potential cost savings and benefits of biosimilar medicines in Australia.

Safety and efficacy
Interdisciplinary insights

Listen to various experts discuss the safety and efficacy of biosimilar medicines.

Clinical experience
Interdisciplinary insights

Listen to various experts discuss the current clinical experience with biosimilar medicines.

Approval and regulation
Interdisciplinary insights

Listen to various experts discuss the approval and regulation of biosimilar medicines.

Biosimilar Medicines
A science success story

A biosimilar medicine is a highly similar version of an original brand of a biological medicine, which enters the market following the patent expiry of the original brand. Watch the video above to learn more.

Video Talk Series
A FOCUS ON PEER-TO-PEER DISCUSSION AND EXPERIENCE

Join fellow healthcare professionals from across Australia for a peer-to-peer exchange of knowledge and clinical experience with biosimilar medicines.

WATCH NOW
Jatinder Harchowal
Chief Pharmacist, Royal Marsden NHS Foundation Trust

Jatinder Harchowal provides an international perspective on the use of biosimilar medicines in the United Kingdom.

view now
Professor Brendan Murphy
Chief Medical Officer, Australian Government

Professor Brendan Murphy is the Chief Medical Officer for the Australian Government and is the principal medical adviser to the Minister and the Department of Health.

VIEW NOW
Professor Paul Bird
Rheumatologist

Prof Bird has over twenty years' experience in treating rheumatic disease, with particular expertise in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

VIEW NOW
A/Professor Andrew Östör
Rheumatologist

A/Prof Östör MD, MA, MB BS, FRACP, FRCP, FRCP (Edin), is a Consultant Rheumatologist at Cabrini Medical Centre and Principle Investigator at Emeritus Research, Melbourne.

VIEW NOW
Professor Jeff Szer
Haematologist

Prof Szer has particular expertise in malignant haematology and haemopoietic stem cell transplantation, which he established as a form of therapy in Victoria in the early 1980s.

VIEW NOW
Professor John Zalcberg
Oncologist

Prof Zalcberg is Head of the Cancer Research Program in the School of Public Health and Preventive Medicine at Monash University.

VIEW NOW
Professor Stephen Clarke
Oncologist

Prof Clarke is a medical oncologist, pharmacologist and translational researcher with major clinical and research interests in gastrointestinal and thoracic cancers.

VIEW NOW
Professor Rodney Sinclair
Dermatologist

Prof Sinclair is Professor of Dermatology at the University of Melbourne and Director of Epworth Dermatology. He is past-president of the Australasian Society for Dermatology Research.

VIEW NOW
Dr. Lena Thin
Gastroenterologist

Dr Thin is a consultant gastroenterologist at Fiona Stanley Hospital, a position she has held for 8 years. Dr Thin is the lead clinical trials investigator for the IBD unit.

VIEW NOW
Dr. Simon Ghaly
Gastroenterologist

Dr Ghaly is Head of the Inflammatory Bowel Disease Service and Staff Specialist at St. Vincent’s Hospital, Sydney. He is also a lecturer at the School of Medicine, UNSW Sydney.

VIEW NOW
David Ford
Pharmacist

Executive Director Pharmacy and Redevelopment, North East Health, and owner and Director, David Ford Healthcare Consulting.

VIEW NOW
Barry Jenkins
pharmacist

Barry has enjoyed a diverse career beginning in community pharmacy and moving into regional and remote hospital pharmacy in WA and far North QLD.

VIEW NOW
GBMA Education Grant Activities
Hon Greg Hunt MP, Minister for Health

“Welcome everybody to the Generic and Biosimilar Medicines Association awareness week discussion”

view now
Dr Paul Cornes, UK Oncologist
APP2018: Biosimilar medicines – the case for change

Dr Cornes is an oncologist in Bristol. He is part of the steering group for the European School of Oncology Working Party on the Access to Innovation in Cancer Treatment.

VIEW NOW
David Ford
Pharmacy Connect 2018: Biologics and biosimilars

David Ford is a proven hospital executive with 30 years of clinical and management experience in hospital administration and department directorship.

VIEW NOW
A/Professor Michael Ward
APP2019: Biosimilar Update

A/Prof Ward continues to practice as a pharmacist and has research interests broadly related to the factors that influence variability in the safety and efficacy of medicines.

VIEW NOW
Benefits and cost savings
INTERDISCIPLINARY INSIGHTS

Listen to various experts discuss the potential cost savings and benefits of biosimilar medicines in Australia.

VIEW NOW
Safety and efficacy
Interdisciplinary insights

Listen to various experts discuss the safety and efficacy of biosimilar medicines.

VIEW NOW
Clinical experience
Interdisciplinary insights

Listen to various experts discuss the current clinical experience with biosimilar medicines.

VIEW NOW
Approval and regulation
Interdisciplinary insights

Listen to various experts discuss the approval and regulation of biosimilar medicines.

VIEW NOW
Biosimilar Medicines
A science success story

A biosimilar medicine is a highly similar version of an original brand of a biological medicine, which enters the market following the patent expiry of the original brand. Watch the video above to learn more.

view now